Related references
Note: Only part of the references are listed.Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models
Lucia Mrazikova et al.
FRONTIERS IN PHARMACOLOGY (2021)
Self-Assembling Peptides: From Design to Biomedical Applications
Sara La Manna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88
Shira Dishon et al.
MOLECULAR PHARMACEUTICS (2019)
TAT-Modified ω-Conotoxin MVIIA for Crossing the Blood-Brain Barrier
Shuo Yu et al.
MARINE DRUGS (2019)
Amphiphilic Endomorphin-1 Derivative Functions as Self-assembling Nanomedicine for Effective Brain Delivery
Hui Liu et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Scalable Self-Assembling Micellar System for Enhanced Oral Bioavailability and Efficacy of Lisofylline for Treatment of Type -I Diabetes
Kishan S. Italiya et al.
MOLECULAR PHARMACEUTICS (2019)
Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
Rolf-Detlef Treede et al.
PAIN (2019)
Self-Assembling Myristoylated Human alpha-Defensin 5 as a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection
Ruyi Lei et al.
ACS NANO (2018)
Involvement of Voltage-Gated Calcium Channels in Inflammation and Inflammatory Pain
Fumiko Sekiguchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Scorpion Toxins Targeting Voltage-gated Sodium Channels Associated with Pain
Yijia Xu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Self-assembly nanostructure controlled sustained release, activity and stability of peptide drugs
Xi-Rui Zhou et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Nicotine evokes kinetic tremor by activating the inferior olive via α7 nicotinic acetylcholine receptors
Naofumi Kunisawa et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Molecular basis of toxicity of N-type calcium channel inhibitor MVIIA
Fei Wang et al.
NEUROPHARMACOLOGY (2016)
Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration
L. Maletinska et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Role of peptide self-assembly in antimicrobial peptides
Xibo Tian et al.
JOURNAL OF PEPTIDE SCIENCE (2015)
A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors
Liberty Francois-Moutal et al.
PAIN (2015)
Pharmacological Inhibition of Voltage-gated Ca2+ Channels for Chronic Pain Relief
Bentham Science Publisher Bentham Science Publisher
Current Neuropharmacology (2013)
Omega-Conotoxins as Experimental Tools and Therapeutics in Pain Management
Heidi E. Hannon et al.
MARINE DRUGS (2013)
Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain
S. Vink et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Interaction of lipidated GBV-C/HGV NS3 (513-522) and (505-514) peptides with phospholipids monolayer. An AFM study
Konrad J. Weronski et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Ziconotide for treatment of severe chronic pain
Achim Schmidtko et al.
LANCET (2010)
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
Howard Howard Smith
Therapeutics and Clinical Risk Management (2010)
Pharmacology of insulin detemir
Peter Kurtzhals
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
Insulin detemir: from concept to clinical experience
P Home et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Enzymatic degradation of beta- and mixed alpha,beta-oligopeptides
Tobias Heck et al.
CHEMISTRY & BIODIVERSITY (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain
DR Wermeling
PHARMACOTHERAPY (2005)
Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues
BD Green et al.
BIOLOGICAL CHEMISTRY (2004)
Actions of intrathecal ω-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat
DA Scott et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Bioavailability of Ziconotide in brain: influx from blood, stability, and diffusion
R Newcomb et al.
PEPTIDES (2000)
Adverse effects associated with the intrathecal administration of ziconotide
RD Penn et al.
PAIN (2000)
Share Paper
